Literature DB >> 27403678

Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage.

Shaun H Pennington1,2, Sherin Pojar1, Elena Mitsi1, Jenna F Gritzfeld1, Elissavet Nikolaou1, Carla Solórzano1, Jessica T Owugha1, Qasim Masood1, Melita A Gordon2,3, Angela D Wright1, Andrea M Collins1, Eliane N Miyaji4, Stephen B Gordon1,3, Daniela M Ferreira1.   

Abstract

RATIONALE: We have previously demonstrated that experimental pneumococcal carriage enhances immunity and protects healthy adults against carriage reacquisition after rechallenge with a homologous strain.
OBJECTIVES: To investigate the role of naturally acquired pneumococcal protein and polysaccharide (PS)-specific immunity in protection against carriage acquisition using a heterologous challenge model.
METHODS: We identified healthy volunteers that were naturally colonized with pneumococcus and, after clearance of their natural carriage episode, challenged them with a heterologous 6B strain. In another cohort of volunteers we assessed 6BPS-specific, PspA-specific, and PspC-specific IgG and IgA plasma and memory B-cell populations before and 7, 14, and 35 days after experimental pneumococcal inoculation.
MEASUREMENTS AND MAIN RESULTS: Heterologous challenge with 6B resulted in 50% carriage among volunteers with previous natural pneumococcal carriage. Protection from carriage was associated with a high number of circulating 6BPS IgG-secreting memory B cells at baseline. There were no associations between protection from carriage and baseline levels of 6BPS IgG in serum or nasal wash, PspA-specific, or PspC-specific memory B cells or plasma cells. In volunteers who did not develop carriage, the number of circulating 6BPS memory B cells decreased and the number of 6BPS plasma cells increased postinoculation.
CONCLUSIONS: Our data indicate that naturally acquired PS-specific memory B cells, but not levels of circulating IgG at time of pneumococcal exposure, are associated with protection against carriage acquisition.

Entities:  

Keywords:  antibodies; memory B cells; plasma B cells; pneumococcal carriage; pneumococcal polysaccharide

Mesh:

Substances:

Year:  2016        PMID: 27403678      PMCID: PMC5215029          DOI: 10.1164/rccm.201512-2467OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  28 in total

Review 1.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

2.  Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization.

Authors:  Tera L McCool; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine.

Authors:  L Salleras; A Domínguez; P Ciruela; C Izquierdo; E Navas; N Torner; E Borras
Journal:  Clin Microbiol Infect       Date:  2009-08-18       Impact factor: 8.067

4.  Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage.

Authors:  Adam K A Wright; Daniela M Ferreira; Jenna F Gritzfeld; Angela D Wright; Kathryn Armitage; Kondwani C Jambo; Emily Bate; Sherouk El Batrawy; Andrea Collins; Stephen B Gordon
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

5.  Interleukin-17A mediates acquired immunity to pneumococcal colonization.

Authors:  Ying-Jie Lu; Jane Gross; Debby Bogaert; Adam Finn; Linda Bagrade; Qibo Zhang; Jay K Kolls; Amit Srivastava; Anna Lundgren; Sophie Forte; Claudette M Thompson; Kathleen F Harney; Porter W Anderson; Marc Lipsitch; Richard Malley
Journal:  PLoS Pathog       Date:  2008-09-19       Impact factor: 6.823

6.  Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children.

Authors:  Sarah Browall; Martin Norman; Jeanette Tångrot; Ilias Galanis; Karin Sjöström; Jessica Dagerhamn; Christel Hellberg; Anuj Pathak; Tiziana Spadafina; Andreas Sandgren; Patrick Bättig; Oscar Franzén; Björn Andersson; Åke Örtqvist; Staffan Normark; Birgitta Henriques-Normark
Journal:  J Infect Dis       Date:  2013-09-05       Impact factor: 5.226

7.  Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.

Authors:  Rebecca A Gladstone; Johanna M Jefferies; Anna S Tocheva; Kate R Beard; David Garley; Wei Wei Chong; Stephen D Bentley; Saul N Faust; Stuart C Clarke
Journal:  Vaccine       Date:  2015-03-14       Impact factor: 3.641

8.  Pneumococcal IgA1 protease subverts specific protection by human IgA1.

Authors:  E N Janoff; J B Rubins; C Fasching; D Charboneau; J T Rahkola; A G Plaut; J N Weiser
Journal:  Mucosal Immunol       Date:  2013-07-03       Impact factor: 7.313

9.  Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.

Authors:  Adam K A Wright; Mathieu Bangert; Jenna F Gritzfeld; Daniela M Ferreira; Kondwani C Jambo; Angela D Wright; Andrea M Collins; Stephen B Gordon
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

10.  Antibody blocks acquisition of bacterial colonization through agglutination.

Authors:  A M Roche; A L Richard; J T Rahkola; E N Janoff; J N Weiser
Journal:  Mucosal Immunol       Date:  2014-06-25       Impact factor: 7.313

View more
  15 in total

Review 1.  Streptococcus pneumoniae: transmission, colonization and invasion.

Authors:  Jeffrey N Weiser; Daniela M Ferreira; James C Paton
Journal:  Nat Rev Microbiol       Date:  2018-06       Impact factor: 60.633

2.  Nasal Pneumococcal Density Is Associated with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial Pathogens.

Authors:  Elena Mitsi; Beatriz Carniel; Jesús Reiné; Jamie Rylance; Seher Zaidi; Alessandra Soares-Schanoski; Victoria Connor; Andrea M Collins; Andreas Schlitzer; Elissavet Nikolaou; Carla Solórzano; Sherin Pojar; Helen Hill; Angela D Hyder-Wright; Kondwani C Jambo; Marco R Oggioni; Megan De Ste Croix; Stephen B Gordon; Simon P Jochems; Daniela M Ferreira
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

Review 3.  Mechanisms Underlying Pneumococcal Transmission and Factors Influencing Host-Pneumococcus Interaction: A Review.

Authors:  Ayumi Morimura; Shigeto Hamaguchi; Yukihiro Akeda; Kazunori Tomono
Journal:  Front Cell Infect Microbiol       Date:  2021-04-28       Impact factor: 5.293

4.  Microinvasion by Streptococcus pneumoniae induces epithelial innate immunity during colonisation at the human mucosal surface.

Authors:  Caroline M Weight; Cristina Venturini; Sherin Pojar; Simon P Jochems; Jesús Reiné; Elissavet Nikolaou; Carla Solórzano; Mahdad Noursadeghi; Jeremy S Brown; Daniela M Ferreira; Robert S Heyderman
Journal:  Nat Commun       Date:  2019-07-16       Impact factor: 14.919

5.  Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccine.

Authors:  Wouter A A de Steenhuijsen Piters; Simon P Jochems; Elena Mitsi; Jamie Rylance; Sherin Pojar; Elissavet Nikolaou; Esther L German; Mark Holloway; Beatriz F Carniel; Mei Ling J N Chu; Kayleigh Arp; Elisabeth A M Sanders; Daniela M Ferreira; Debby Bogaert
Journal:  Nat Commun       Date:  2019-07-05       Impact factor: 14.919

6.  Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization.

Authors:  Simon P Jochems; Karin de Ruiter; Carla Solórzano; Astrid Voskamp; Elena Mitsi; Elissavet Nikolaou; Beatriz F Carniel; Sherin Pojar; Esther L German; Jesús Reiné; Alessandra Soares-Schanoski; Helen Hill; Rachel Robinson; Angela D Hyder-Wright; Caroline M Weight; Pascal F Durrenberger; Robert S Heyderman; Stephen B Gordon; Hermelijn H Smits; Britta C Urban; Jamie Rylance; Andrea M Collins; Mark D Wilkie; Lepa Lazarova; Samuel C Leong; Maria Yazdanbakhsh; Daniela M Ferreira
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 19.456

Review 7.  The immunological mechanisms that control pneumococcal carriage.

Authors:  Simon P Jochems; Jeffrey N Weiser; Richard Malley; Daniela M Ferreira
Journal:  PLoS Pathog       Date:  2017-12-21       Impact factor: 6.823

8.  Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage.

Authors:  E Mitsi; A M Roche; J Reiné; T Zangari; J T Owugha; S H Pennington; J F Gritzfeld; A D Wright; A M Collins; S van Selm; M I de Jonge; S B Gordon; J N Weiser; D M Ferreira
Journal:  Mucosal Immunol       Date:  2016-08-31       Impact factor: 7.313

9.  Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization.

Authors:  Hans de Graaf; Muktar Ibrahim; Alison R Hill; Diane Gbesemete; Andrew T Vaughan; Andrew Gorringe; Andrew Preston; Annemarie M Buisman; Saul N Faust; Kent E Kester; Guy A M Berbers; Dimitri A Diavatopoulos; Robert C Read
Journal:  Clin Infect Dis       Date:  2020-07-11       Impact factor: 9.079

10.  A pneumococcal controlled human infection model in Malawi: Transfer of an established pneumococcal carriage model from Liverpool, UK to Blantyre, Malawi - A feasibility study.

Authors:  Ben Morton; Sarah Burr; Kondwani Jambo; Jamie Rylance; Marc Y R Henrion; Ndaziona Peter Banda; Edna Nsomba; Blessings Kapumba; Lucinda Manda-Taylor; Clemens Masesa; Daniela Ferrreira; Stephen B Gordon
Journal:  Wellcome Open Res       Date:  2020-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.